Skip to main content
Clinical Trials/NCT01534650
NCT01534650
Completed
N/A

Movement Disorder Quantification Algorithm Development

Great Lakes NeuroTechnologies Inc.1 site in 1 country17 target enrollmentFebruary 2012

Overview

Phase
N/A
Intervention
Not specified
Conditions
Parkinson's Disease
Sponsor
Great Lakes NeuroTechnologies Inc.
Enrollment
17
Locations
1
Primary Endpoint
Processed kinematics
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The purpose of this study is to collect kinematic motion data from subjects with movement disorders such as Parkinson's disease (PD) and essential tremor (ET) to develop and validate algorithms for quantifying motor symptoms such as tremor, bradykinesia (slowed movements), dyskinesias (sudden, involuntary movements), gait, and balance during standardized tasks and/or activities of daily living.

Registry
clinicaltrials.gov
Start Date
February 2012
End Date
January 2016
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Aged 18 years or older
  • Clinical diagnosis of idiopathic Parkinson's disease or essential tremor
  • Able to provide informed consent

Exclusion Criteria

  • Significant medical or psychiatric illness
  • Not capable of following the required clinical instructions
  • Serious medical conditions that compromise safety

Outcomes

Primary Outcomes

Processed kinematics

Time Frame: During assessment

Motion data collected during various motor tasks will be processed and compared to video review.

Study Sites (1)

Loading locations...

Similar Trials